CN Patent

CN120478294A — 制备咪唑并[1,2-a]吡咯并[2,3-e]吡嗪类化合物及其固态形式的方法

Assigned to AbbVie Inc · Expires 2025-08-15 · 1y expired

What this patent protects

本发明涉及制备(3S,4R)‑3‑乙基‑4‑(3H‑咪唑并[1,2‑A]吡咯并[2,3‑E]吡嗪‑8‑基)‑N‑(2,2,2‑三氟乙基)吡咯烷‑1‑甲酰胺及其固态形式的方法。本披露涉及用于制备(3S,4R)‑3‑乙基‑4‑(3H‑咪唑并[1,2‑a]吡咯并[2,3‑e]吡嗪‑8‑基)‑N‑(2,2,2‑三氟乙基)吡咯烷‑1‑甲酰胺、其固态形式、和相应的药物组合物的方法、治疗(包括治疗类风湿性关节炎)的方法、试剂盒、合成方法、以及由方法表征的产品(products‑by‑process)。

USPTO Abstract

本发明涉及制备(3S,4R)‑3‑乙基‑4‑(3H‑咪唑并[1,2‑A]吡咯并[2,3‑E]吡嗪‑8‑基)‑N‑(2,2,2‑三氟乙基)吡咯烷‑1‑甲酰胺及其固态形式的方法。本披露涉及用于制备(3S,4R)‑3‑乙基‑4‑(3H‑咪唑并[1,2‑a]吡咯并[2,3‑e]吡嗪‑8‑基)‑N‑(2,2,2‑三氟乙基)吡咯烷‑1‑甲酰胺、其固态形式、和相应的药物组合物的方法、治疗(包括治疗类风湿性关节炎)的方法、试剂盒、合成方法、以及由方法表征的产品(products‑by‑process)。

Drugs covered by this patent

Patent Metadata

Patent number
CN120478294A
Jurisdiction
CN
Classification
—
Expires
2025-08-15
Drug substance claim
No
Drug product claim
No
Assignee
AbbVie Inc
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.